Estradiol topical - LaSalle Laboratories

Drug Profile

Estradiol topical - LaSalle Laboratories

Alternative Names: Estradiol gel - LaSalle Laboratories; Estrogel; OEstroGel

Latest Information Update: 02 May 2017

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator LaSalle Laboratories
  • Developer Abbott Laboratories; LaSalle Laboratories
  • Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
  • Mechanism of Action Estrogen receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Atrophic vaginitis; Menopausal syndrome; Vasomotor symptoms

Most Recent Events

  • 05 Aug 2014 ASCEND Therapeutics and Aeterna Zentaris agree to co-promote estradiol topical in USA for Menopausal syndrome
  • 20 Aug 2013 Biomarkers information updated
  • 04 Apr 2011 Launched for Menopausal syndrome in Chile (Transdermal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top